Fig. 4From: Clinical trials from the patient perspective: survey in an online patient community a, b. Trial satisfaction (a) and Net Promoter Score (b) by primary condition (patient’s chief complaints). Patients with Parkinson’s disease and MS were likely to endorse trials to other patients; in RA and Epilepsy participants were more likely to dissuade other patients like them from taking part in trials. Overall, 58% patients were “Very” to “Extremely” satisfied with the trials they partook in. Error bars represent 95% Confidence Intervals (95% CI)Back to article page